BENZENE DERIVATIVES, PROCESS FOR PREPARING THE SAME AND USE THEREOF

Details for Australian Patent Application No. 2002332331 (hide)

Owner TAKEDA CHEMICAL INDUSTRIES, LTD.

Inventors MOCHIZUKI, Manabu; MATSUMOTO, Takahiro; YAMAMOTO, Masataka; NAGABUKURO, Hiroshi

Pub. Number AU-A-2002332331

PCT Number PCT/JP02/09995

PCT Pub. Number WO2003/029199

Priority 2001-300564 28.09.01 JP

Filing date 27 September 2002

Wipo publication date 14 April 2003

International Classifications

C07C 275/38 Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07C 275/42 Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07D 213/30 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/40 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/65 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/75 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 261/14 Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 295/20 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 317/58 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 317/66 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 319/18 Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 321/10 Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups

A61K 031/17 - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 031/216

A61K 031/357 - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 031/36

A61K 031/4045

A61K 031/4184

A61K 031/42 - Oxazoles

A61K 031/44 - Non-condensed pyridines

A61K 031/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

A61K 031/4453 - only substituted in position 1, e.g. propipocaine, diperodon

A61K 031/4468 - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 031/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 001/06 Drugs for disorders of the alimentary tract or the digestive system

A61P 001/08 Drugs for disorders of the alimentary tract or the digestive system

A61P 001/14 Drugs for disorders of the alimentary tract or the digestive system

A61P 003/04 Drugs for disorders of the metabolism

A61P 003/06 Drugs for disorders of the metabolism

A61P 003/08 Drugs for disorders of the metabolism

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 009/02 Drugs for disorders of the cardiovascular system

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 011/02 Drugs for disorders of the respiratory system

A61P 013/02 Drugs for disorders of the urinary system

A61P 015/12 Drugs for genital or sexual disorders

A61P 017/00 Drugs for dermatological disorders

A61P 017/04 Drugs for dermatological disorders

Event Publications

6 February 2003 Complete Application Filed

  Priority application(s): 2001-300564 28.09.01 JP

26 June 2003 Application Open to Public Inspection

  Published as AU-A-2002332331

17 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002332332-HONEYCOMB STRUCTURAL BODY AND METHOD OF MANUFACTURING THE STRUCTURAL BODY

2002332330-Radiation detector